
Today’s Sleep Patterns Predict, Prevent Tomorrow’s Alzheimer’s
NEUROSCIENTISTS have discovered they can estimate when Alzheimer’s is most likely to strike a person, based on his or her sleep pattern. The best defense:

NEUROSCIENTISTS have discovered they can estimate when Alzheimer’s is most likely to strike a person, based on his or her sleep pattern. The best defense:

BREAKTHROUGH: FOR THE FIRST TIME in 18 years, the FDA approved a new Alzheimer’s drug. The new medication’s generic name is aducanumab and will be marketed under the brand name Aduhelm. Another first is the drug’s ability to potentially slow down Alzheimer’s, not just cover up its symptoms, as existing medications do. Find out more.

ADVANCES IN DEMENTIA CARE – VIDEO: Dementia-Villages are catching on, with France building the largest one yet. At $28 million, take a quick look at

BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a “Breakthrough Therapy” designation for donanemab, a potential new treatment for people with early symptomatic

BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so

DIAGNOSIS: The PrecivityAD™ blood test accurately and reliably detected brain amyloid on a single blood sample. Intended for people with memory and thinking issues, the

RESEARCH: Scientists are using gold nanoparticles to create new images of the amyloid fibrils associated with Alzheimer’s disease and other neurodegenerative disorders. The fibrils are

Researchers studying Australians with type 2 diabetes found those taking the first-line treatment medication metformin had significantly slower cognitive decline compared to those who did

MEDICATION TRIALS: The FDA has accepted Biogen’s application for aducanumab, an investigational treatment for Alzheimer’s, and even granted it Priority Review, with an action date

GENETICS & ALZHEIMER’S: Women’s second “X” chromosome provides them with more longevity, and researchers are finding they also have extra protection against Alzheimer’s as well,

COCHRANE SERIES, PART 3 – DEEP DIVE: False alarm. The Cochrane Review shook confidence in Leqembi. It rests on a scientific threshold its own source publicly disowned. Here’s why the evidence did not justify the alarm.

When we honestly ask ourselves, which person in our lives means the most to us, We find that it is those who have chosen to

COCHRANE SERIES, PART 2 – HOW IT HAPPENED: A new review just went viral in the media, declaring Alzheimer’s drugs don’t work. Leading scientists say the methodology was fundamentally flawed.

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.

TEEPA CARE VIDEO: Learn about Alzheimer’s 6 stages. Teepa Snow shows what to expect, while keeping the focus on the person for whom you care.
No spam, only news and updates.



We use cookies and similar technologies to improve your experience, understand how our content is used, and support relevant advertising that helps keep Alzheimer’s Weekly free to readers. You can choose to accept, deny, or manage your preferences at any time. Declining certain cookies may affect features such as embedded videos, comments, and personalized advertising.